University of Campania Luigi Vanvitelli
🇮🇹Italy
Clinical Trials
162
Active:3
Completed:104
Trial Phases
5 Phases
Phase 1:4
Phase 2:7
Phase 3:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (81 trials with phase data)• Click on a phase to view related trials
Not Applicable
38 (46.9%)Phase 4
26 (32.1%)Phase 2
7 (8.6%)Phase 3
6 (7.4%)Phase 1
4 (4.9%)Screening for Postpartum Depression Using EPDS and HAM-D in Mothers Within 72 Hours After Delivery at a Tertiary Care Center (SOS-Mamma Study)
Not yet recruiting
- Conditions
- Post Partum Depression
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- University of Campania Luigi Vanvitelli
- Target Recruit Count
- 273
- Registration Number
- NCT07025902
- Locations
- 🇮🇹
Largo Madonna delle grazie 1, Naples, Italy
The Brain&Senses Study
Not yet recruiting
- Conditions
- Mild Cognitive ImpairmentAlzheimer DiseaseParkinson
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- University of Campania Luigi Vanvitelli
- Target Recruit Count
- 100
- Registration Number
- NCT06991816
- Locations
- 🇮🇹
Vanvitelli ENT department, Naples, Campania, Italy
Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis
Completed
- Conditions
- Pulmonary Fibrosis
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- University of Campania Luigi Vanvitelli
- Target Recruit Count
- 59
- Registration Number
- NCT06974799
- Locations
- 🇮🇹
UOC Clinica Pneumologica L Vanvitelli, Naples, Italy
DNA Methylation in Brugada Syndrome and Risk of Sudden Cardiac Death
Not yet recruiting
- Conditions
- Brugada SyndromeSudden Cardiac Death Due to Cardiac Arrhythmia
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- University of Campania Luigi Vanvitelli
- Target Recruit Count
- 10
- Registration Number
- NCT06888271
Virtual Reality on Anxiety Management During Elective Surgery
Not Applicable
Completed
- Conditions
- AnxietyDiscomfortPain Intensity Assessment
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- University of Campania Luigi Vanvitelli
- Target Recruit Count
- 233
- Registration Number
- NCT06877663
- Locations
- 🇮🇹
University of Campania Luigi Vanvitelli, Caserta, CE, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 33
- Next
News
Variant Secures EMA Endorsement for VAR002 Gene Therapy Targeting Inherited Retinal Dystrophies
The European Medicines Agency has provided positive scientific advice on Variant's VAR002, an adeno-associated viral vector gene therapy targeting inherited retinal dystrophies linked to CRX mutations.